BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 7126423)

  • 1. Surveillance strategies following curative resection and non-operative approach of rectal cancer: How and how long? Review of current recommendations.
    Lauretta A; Montori G; Guerrini GP
    World J Gastrointest Surg; 2023 Feb; 15(2):177-192. PubMed ID: 36896297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood CEA levels for detecting recurrent colorectal cancer.
    Nicholson BD; Shinkins B; Pathiraja I; Roberts NW; James TJ; Mallett S; Perera R; Primrose JN; Mant D
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011134. PubMed ID: 26661580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the decreased rate of perioperative serum carcinoembryonic antigen level in the patients with colon cancer after a curative resection.
    Jung TD; Yoo JH; Lee MJ; Park HK; Shin JH; An MS; Ha TK; Kim KH; Bae KB; Kim TH; Choi CS; Oh MK; Hong KH
    Ann Coloproctol; 2013 Jun; 29(3):115-22. PubMed ID: 23862129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CEA in the follow-up of colorectal carcinoma: experience in a district general hospital.
    Allen-Mersh TG
    Ann R Coll Surg Engl; 1984 Jan; 66(1):14-6. PubMed ID: 6691692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
    Chester KA; Begent RH
    Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen and recurrent colorectal cancer.
    Northover J
    Gut; 1986 Feb; 27(2):117-22. PubMed ID: 3949243
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic validity of CEA determination in metastasizing breast cancer].
    Krieger G; Prangen M; Klar R; Kneba M; Bandlow G; Nagel GA
    Klin Wochenschr; 1986 Aug; 64(15):701-7. PubMed ID: 3762017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and preliminary characterisation of cDNA clones representing mRNAs associated with tumour progression and metastasis in colorectal cancer.
    Elvin P; Kerr IB; McArdle CS; Birnie GD
    Br J Cancer; 1988 Jan; 57(1):36-42. PubMed ID: 2450556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterisation of human carcinoembryonic antigen transgenic mice.
    Hasegawa T; Isobe K; Tsuchiya Y; Oikawa S; Nakazato H; Ikezawa H; Nakashima I; Shimokata K
    Br J Cancer; 1991 Oct; 64(4):710-4. PubMed ID: 1911219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoembryonic antigen and recurrent colorectal cancer.
    Northover JM
    Br J Surg; 1985 Sep; 72 Suppl():S44-6. PubMed ID: 3899260
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma CEA in the post-surgical monitoring of colorectal carcinoma.
    Tate H
    Br J Cancer; 1982 Sep; 46(3):323-30. PubMed ID: 7126423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective monitoring trial for carcinoma of colon and rectum after surgical resection.
    Wanebo HJ; Llaneras M; Martin T; Kaiser D
    Surg Gynecol Obstet; 1989 Dec; 169(6):479-87. PubMed ID: 2683153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CEA assays in postoperative detection of recurrent colorectal carcinoma (author's transl)].
    Kato K; Morimoto T; Kato T; Yasue M; Takagi H; Kito T; Nakazato H; Miyaishi S; Yamada E; Kuwabara M; Suchi T
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1137-42. PubMed ID: 7229472
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.